276 related articles for article (PubMed ID: 19387588)
1. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
2. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
3. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antitumor activity of new substituted thiopyrimidine acyclic nucleosides and their thioglycoside analogs.
El-Sayed WA; Rashad AE; Awad SM; Ali MM
Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):261-74. PubMed ID: 20183580
[TBL] [Abstract][Full Text] [Related]
9. Regioselective one-pot synthesis and anti-proliferative and apoptotic effects of some novel tetrazolo[1,5-a]pyrimidine derivatives.
Hussein AM; Ahmed OM
Bioorg Med Chem; 2010 Apr; 18(7):2639-44. PubMed ID: 20227281
[TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamide.
Andreani A; Rambaldi M; Locatelli A; Andreani F; Lollini PL; Nanni P; Bossa R; Galatulas I
Farmaco; 1993 Nov; 48(11):1503-13. PubMed ID: 8110363
[TBL] [Abstract][Full Text] [Related]
11. Isolation, purification and antitumor activity of lipopolysaccharide from cow placenta.
Li H; Lu X; Lu M; Liu H
Int J Biol Macromol; 2008 Oct; 43(3):232-7. PubMed ID: 18582932
[TBL] [Abstract][Full Text] [Related]
12. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of trans-bis(salicylaldoximato)copper(II): a novel antiproliferative metal complex.
Elo HO; Lumme PO
Cancer Treat Rep; 1985 Sep; 69(9):1021-2. PubMed ID: 4028035
[TBL] [Abstract][Full Text] [Related]
16. Alkylphosphonium salts as a new class of antitumor agents.
Sanyal U; Chatterjee RS; Das SK; Chakraborti SK
Neoplasma; 1984; 31(2):149-55. PubMed ID: 6717684
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
18. The bioflavonoid galangin suppresses the growth of ehrlich ascites carcinoma in Swiss Albino mice: a molecular insight.
Jaiswal JV; Wadegaonkar PA; Hajare SW
Appl Biochem Biotechnol; 2012 Jul; 167(5):1325-39. PubMed ID: 22434356
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)-1-methylhydrazines as anticancer agents.
Sanyal U; De R; Dutta S; Das H; Ghost M
Neoplasma; 1993; 40(4):219-22. PubMed ID: 8272148
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models.
Suzuki T; Fujii A; Ohya J; Nakamura H; Fujita F; Koike M; Fujita M
Cancer Sci; 2009 Aug; 100(8):1526-31. PubMed ID: 19459856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]